You are here
Articles on Gastrointestinal Cancer
A selection of peer-reviewed articles on Gastrointestinal Cancer. All content available on the Advances in Gastrointestinal Cancer Resource Center, including original and review articles, interviews, guidelines and congress highlights, is independently selected by the members of the Editorial Board.
Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial
Kerr RS, Love S, Segelov E, Johnstone E, Falcon B, Hewett P, et al.Lancet Oncol 2016;17:1543-1557.
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Bruix J, Qin S, Merle P, Granito A, Huang YH, Bodoky G, et al.Lancet 2016 Dec. [Epub ahead of print]
Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized, double-blind, multicenter Phase II trial
Yoon HH, Bendell JC, Braiteh FS, Firdaus I, Philip PA, Cohn AL, et al.Ann Oncol 2016;27:2196-2203.
Biomarker analyses in REGARD gastric/GEJ carcinoma patients treated with VEGFR2-targeted antibody ramucirumab
Fuchs CS, Tabernero J, Tomášek J, Chau I, Melichar B, Safran, et al.Br J Cancer 2016;115:974-982.
Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma(FLOT4-AIO)
Al-Batran SE, Hofheinz RD, Pauligk C, Kopp HG, Haag GM, Luley KB, et al.Lancet Oncol. 2016 Dec;17(12):1697-1708.
Reversible Posterior Leukoencephalopathy Syndrome During Regorafenib Treatment: A Case Report and Literature Review of Reversible Posterior Leukoencephalopathy Syndrome Associated With Multikinase Inhibitors
Zaw W. Myint, Jeremy M. Sen, Nicole L. Watts, Thomas J. Druzgal, Barnett R. Nathan, Melanie D. Ward, James E. Boyer, Paula M. Fracasso
Clinical Colorectal Cancer, Volume 13, Issue 2, June 2014, Pages 127 - 130
Jane E. Rogers, Aki Ohinata, Arvind Dasari, Cathy Eng
Clinical Colorectal Cancer, Volume 13, Issue 1, March 2014, Pages e1 - e4
Successful Completion of Adjuvant Chemotherapy in a Patient With Colon Cancer Experiencing 5-Fluorouracil–Induced Cardiac Vasospasm
Craig A. Vargo, Marlo Blazer, Joshua Reardon, Martha Gulati, Tanios Bekaii-Saab
Clinical Colorectal Cancer, Volume 15, Issue 2, June 2016, Pages e61 - e63
Posterior Reversible Encephalopathy Syndrome (PRES) After Treatment With Oxaliplatin and 5-Fluorouracil
Nicholas Truman, Daniel Nethercott
Clinical Colorectal Cancer, Volume 12, Issue 1, March 2013, Pages 70 - 72
Oxaliplatin-Induced Hepatoportal Sclerosis, Portal Hypertension, and Variceal Bleeding Successfully Treated With Transjugular Intrahepatic Portosystemic Shunt
Taoreed O. Lawal, Alton B. Farris, Bassel F. El-Rayes, Ram M. Subramanian, Hyun S. Kim
Clinical Colorectal Cancer